EUVIMEDEUVIMED entdecken
Open Access

CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells

Zhenxing Wang, Lanxin Li, Chunhong Chu, Xiangkai Wei, Qian Liu, Rui Wang, Guoliang Zhang, Guangyao Wu, Ying Wang, Lei An, Xiaodong Li

International Journal of Oncology · 2023

DOI: 10.3892/ijo.2023.5579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Zhenxing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, Henan 475000, P.R. China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsAntineoplastic AgentsHumansQuinazolinesCell ProliferationApoptosisErbB ReceptorsCell Line, TumorHydroxamic Acids

Stichwörter der Autor:innen

CUDC‑101EGFRbladder cancercytotoxicologyproliferation

Substanzen

Antineoplastic AgentsQuinazolinesErbB Receptors7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamideHydroxamic AcidsEGFR protein, human

Autor:innen und Institutionen

  • Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, Henan 475000, P.R. China.
  • School of Pharmacy, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, Henan 475000, P.R. China.
  • Department of Anesthesiology, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, Henan 475000, P.R. China.

Zitieren

APA

Wang, Z., Li, L., Chu, C., Wei, X., Liu, Q., Wang, R., Zhang, G., Wu, G., Wang, Y., An, L., & Li, X. (2023). CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells. International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5579

Vancouver

Wang Z, Li L, Chu C, Wei X, Liu Q, Wang R, et al. CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells. International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5579

BibTeX
@article{Wang2023,
  author = {Wang, Zhenxing and Li, Lanxin and Chu, Chunhong and Wei, Xiangkai and Liu, Qian and Wang, Rui and Zhang, Guoliang and Wu, Guangyao and Wang, Ying and An, Lei and Li, Xiaodong},
  title = {CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells},
  journal = {International Journal of Oncology},
  year = {2023},
  doi = {10.3892/ijo.2023.5579}
}
Kostenlos starten →